Possible Administrative Guidance against ノバルティス株式会社
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E3%83%8E%E3%83%90%E3%83%AB%E3%83%86%E3%82%A3%E3%82%B9%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&limit=10Action summary
- Company
- ノバルティス株式会社Japanese originalOriginal: ノバルティス株式会社
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Administrative Guidance行政指導
- Action date
- 16 April 2014
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Show original Japanese text
医薬品の交付に当たっては、医薬品の状態を十分に観察し、異常が無いことの確認をする必要があります。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-05-06T00:02:06.771+00:00
- Evidence checked
- 2026-05-06T00:02:06.771+00:00
- Archive captured
- 2026-05-06T00:02:07.55+00:00
Show audit JSON
{
"record": {
"id": "1817161e-c6ed-46a8-a323-d3fc0e2e18de",
"url": "https://regbase.jp/en/enforcement/yakkiho-nobaruteisu-20140416",
"company_name_original": "ノバルティス株式会社",
"company_name_registry": "ノバルティス株式会社",
"corporate_number": null,
"law": {
"ja": "薬機法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "行政指導",
"en": "Administrative Guidance"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Low-medium",
"actionMeaning": "Administrative guidance or supervision was publicly disclosed by the authority.",
"practicalNote": "Use as a monitoring signal. Confirm details before treating it as a formal sanction.",
"lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/yakkiho-nobaruteisu-20140416",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000043739.html",
"archiveUrl": "https://kiroku.today/view/7e2914fa44talzl8",
"archiveCapturedAt": "2026-05-06T00:02:07.55+00:00",
"extractedAt": "2026-05-06T00:02:06.771+00:00",
"translatedAt": null,
"evidenceCheckedAt": "2026-05-06T00:02:06.771+00:00",
"generatedAt": "2026-05-20T22:31:49.731Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.